Holen Sie sich die Stockscreener-App
78.29
1.74%
-1.39
Handel nachbörslich:
78.31
0.02
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$79.68
Offen:
$78.89
24-Stunden-Volumen:
1.31M
Relative Volume:
0.70
Marktkapitalisierung:
$38.49B
Einnahmen:
$10.03B
Nettoeinkommen (Verlust:
$1.07B
KGV:
36.08
EPS:
2.17
Netto-Cashflow:
$1.39B
1W Leistung:
-2.35%
1M Leistung:
-9.00%
6M Leistung:
-11.82%
1J Leistung:
-22.30%
1-Tages-Spanne:
$78.28
$79.04
1-Wochen-Bereich:
$77.44
$80.06
52-Wochen-Spanne:
$77.44
$100.71
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
STAAR Surgical's largest holder to vote against Alcon bid - MSN
Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN
The past year for Alcon (VTX:ALC) investors has not been profitable - Yahoo Finance
Exclusive: Shareholder revolt threatens Alcon’s takeover of STAAR Surgical - Investing.com
New company OpZira formed following Alcon’s acquisition of LumiThera - Ophthalmology Times
Alcon AG stock hits 52-week low at 77.71 USD By Investing.com - Investing.com Nigeria
Alcon announces launch of wavelight plus, fully personalized LASIK treatment, in US and Canada - Ophthalmology Times
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders - GlobeNewswire Inc.
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Alcon AG stock hits 52-week low at 77.71 USD - Investing.com
Alcon launches first fully personalized LASIK treatment - Eyes On Eyecare
Alcon completes acquisition of LumiThera - Modern Retina
Swing Trade: Will Alcon Inc. benefit from rate cutsWeekly Gains Report & Real-Time Stock Price Movement Reports - Lancaster City Council
Does Alcon Inc. offer margin of safetyCPI Data & Technical Entry and Exit Alerts - Lancaster City Council
Alcon announces first fully personalized LASIK treatment with wavelight plus in the US and Canada - Eyes On Eyecare
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL - Yahoo Finance
Eye Care’s Digital Revolution: Alcon’s ESCRS 2025 Launches Signal the Future of a $90B Market - MarketsandMarkets
Dana Lynn Alcon Obituary (2025)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
Short Term Trend Reversal in Alcon Inc. PossibleJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
Candlestick Reversal Detected on Alcon Inc.’s ChartTrade Signal Summary & High Conviction Buy Zone Picks - beatles.ru
Alcon Inc. Volume Confirms Breakout — Analysts Bullish2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
Alcon Inc. Moves Into Bullish Territory Based on MACDJuly 2025 PreEarnings & Verified Momentum Watchlists - beatles.ru
Is Alcon Inc. Forming a Bottom PatternJuly 2025 Technicals & Free Accurate Trade Setup Notifications - beatles.ru
Alcon Launches Innovations and Highlights New Study Findings At ESCRS 2025 - MarketScreener
Alcon Inc. Recovery Potential Based on Technical ToolsAnalyst Downgrade & Real-Time Chart Pattern Alerts - beatles.ru
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 - Yahoo Finance
Alcon downgraded at J.P. Morgan on Q2 results - MSN
Heatmap analysis for Alcon Inc. and competitorsQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Fundamentals Check: Is Alcon Inc. stock technically oversoldJuly 2025 Snapshot & Weekly High Return Opportunities - خودرو بانک
Is Alcon Inc. a play on infrastructure spending2025 Trading Volume Trends & AI Driven Price Forecasts - خودرو بانک
What is Alcon Inc.’s book value per shareJuly 2025 PostEarnings & Target Return Focused Picks - خودرو بانک
Alcon officially purchases LumiThera - Eyes On Eyecare
Forecasting Alcon Inc. price range with options dataShare Buyback & Verified Trade Idea Suggestions - Newser
With 64% ownership of the shares, Alcon Inc. (VTX:ALC) is heavily dominated by institutional owners - simplywall.st
Alcon Completes Acquisition of LumiThera, Expands Footprint Into Retina Clinic and Dry AMD Space - VisionMonday.com
Technical analysis overview for Alcon Inc. stock2025 Market WrapUp & Community Trade Idea Sharing - Newser
Can Alcon Inc. hit a new high this monthJuly 2025 Short Interest & High Conviction Trade Alerts - Newser
Will earnings trigger a reversal in Alcon Inc.Weekly Earnings Recap & Verified Short-Term Plans - Newser
Alcon and GRAIL: Unlocking Innovation and Efficiency through Strategic Partnerships - Veeva
STAAR Surgical’s largest shareholder opposes Alcon takeover - MSN
Opzira launches with former Lumithera diagnostics - BioWorld MedTech
Creation of OpZira Inc. announced following Alcon's acquisition of LumiThera - Ophthalmology Times
Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval - MSN
Detecting support and resistance levels for Alcon Inc.IPO Watch & Short-Term Swing Trade Alerts - Newser
Alcon Inc. stock trendline breakdownJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Why Alcon Inc. is moving todayJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Is Alcon Inc. trending in predictive chart modelsMarket Weekly Review & Daily Stock Trend Watchlist - Newser
What momentum shifts mean for Alcon Inc.July 2025 Decliners & Community Consensus Picks - Newser
Real time scanner hits for Alcon Inc. explainedJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Alcon Inc. outperform the market2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):